Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead
作者:David L. Carlton、Lissa J. Collin-Smith、Alejandro J. Daniels、David N. Deaton、Aaron S. Goetz、Christopher P. Laudeman、Thomas R. Littleton、David L. Musso、Ronda J. Ott Morgan、Jerzy R. Szewczyk、Cunyu Zhang
DOI:10.1016/j.bmcl.2008.09.033
日期:2008.10
Starting from a weak omeprazole screening hit, replacement of the pyridine with a 1,3-benzodioxole moiety, modi. cation of the thioether linkage, and substitution of the benzimidazole pharmacophore led to the discovery of nanomolar BRS-3 agonists. (c) 2008 Elsevier Ltd. All rights reserved.